This tender with title 831089-Awarded - Czech Republic – Antineoplastic agents – Medicinal products containing nivolumab and relatlimab, cisplatin, talazoparib, ivosidenib, hydroxycarbamide, aflibercept, tebentafusp -- Contract Value: 66 149 422,70 CZK has been published on Bidding Source portal dated 18 Dec 2025 for the country of Czech Republic. It has been categorized on Antineoplastic agents. For similar tenders you can see tenders mentioned below of this page.
Contract Value: 66 149 422,70 CZK
General Information
Contract Value: 66 149 422,70 CZK
For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now
Or Request a call back now and one of our representatives will contact you. Contact us